Nutex Health Financial Ratios
NASDAQ: NUTXConsumer DiscretionaryBusiness ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Nutex Health ratio analysis
Nutex Health earned a net margin of 8.1% in FY 2025, down from 10.9% a year earlier. Gross margin was 50.8% compared with a median of 40.1% over the prior 8 years. Return on equity reached 21.5%, meaning Nutex Health generated 0.21 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.13 versus 0.28 the year before, and the current ratio was 3.41. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Nutex Health financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 14.14 | 3.50 | — | — | — | — | — | — | — | — |
| Price / sales | 1.08 | 0.36 | 0.48 | 5.50 | — | — | — | — | — | — |
| Price / book | 2.86 | 1.30 | 1.94 | 12.58 | — | — | — | — | — | — |
| Gross margin | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% | 57.5% | 39.2% | 62.9% | -31.6% | — |
| Operating margin | 31.5% | 27.2% | -12.8% | -185.4% | 51.4% | 55.9% | -504.8% | -61.5% | -24,574.5% | — |
| Net margin | 8.1% | 10.9% | -18.5% | -193.7% | 40.0% | 38.7% | -520.8% | -69.5% | 2,512.6% | — |
| Free cash flow margin | 28.1% | 4.3% | -3.3% | 16.4% | 41.2% | 9.3% | -301.9% | -35.1% | -3,084.8% | — |
| Return on equity (ROE) | 21.5% | 39.3% | -74.5% | -443.1% | 115.6% | — | -382.9% | — | — | — |
| Return on assets (ROA) | 7.7% | 7.9% | -11.5% | -98.4% | 33.6% | 62,387.7% | -106.3% | -211.4% | 17.5% | -1,454.9% |
| Debt / equity | 0.13 | 0.28 | 0.60 | 0.37 | 1.47 | — | 0.00 | — | — | — |
| Current ratio | 3.41 | 1.90 | 1.56 | 1.79 | 4.09 | 0.14 | 0.27 | 0.29 | 0.06 | 0.08 |
| Revenue growth | 82.4% | 93.8% | 12.9% | -33.9% | 21.0% | 19,954.5% | -0.0% | 5,800.9% | — | -100.0% |
| EPS growth | 8.2% | — | — | -45,718.2% | 22.2% | — | — | -5,700.0% | — | — |